Health Professional Radio - Podcast

Dr. Stephanie Culler, Ph.D., co-founder and CEO of Persephone Biosciences discusses their VOICES (Vaccine Observation to Include all Communities for Equitable Science) study, a non-interventional, single-site study enrolling people in the U.S. being administered a COVID-19 vaccine. The goal is to identify and determine specific gut microbiota and the metabolic processes that are involved in an optimal immune response. Dr. Culler is a graduate of the prestigious Y Combinator accelerator, a recipient of the BIOCOM catalyst award and has spoken at TEDx San Diego. Prior to establishing Persephone Biosciences, she was a senior scientist at Genomatica, where she developed novel microbial synthetic biology technologies for industrial metabolic engineering and led their syngas to chemicals and bio-based butadiene (major component of tires) from renewable feedstocks programs. Dr. Culler also led the development of cell-free transcription-translation (TX-TL) for industrial metabolic engineering as well as the applicati